Temgesic 0,3 mg/ml injektionsvæske, opløsning Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

temgesic 0,3 mg/ml injektionsvæske, opløsning

eumedica pharmaceuticals gmbh - buprenorphinhydrochlorid - injektionsvæske, opløsning - 0,3 mg/ml

Ulcerex 40 mg enterokapsler, hårde Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

ulcerex 40 mg enterokapsler, hårde

aristo pharma gmbh - esomeprazolmagnesiumdihydrat - enterokapsler, hårde - 40 mg

Besremi Den Europæiske Union - dansk - EMA (European Medicines Agency)

besremi

aop orphan pharmaceuticals gmbh - ropeginterferon alfa-2b - polycythemia vera - immunostimulants, - besremi er angivet som monoterapi hos voksne til behandling af polycythaemia vera uden symptomatisk splenomegali.

Grasustek Den Europæiske Union - dansk - EMA (European Medicines Agency)

grasustek

juta pharma gmbh - pegfilgrastim - neutropeni - immunostimulants, - reduktion i varigheden af neutropeni og forekomst af febril neutropeni hos voksne patienter behandlet med cytotoksisk kemoterapi for malignitet (med undtagelse af kronisk myeloid leukæmi og myelodysplastisk syndromer).

Thiotepa Riemser Den Europæiske Union - dansk - EMA (European Medicines Agency)

thiotepa riemser

esteve pharmaceuticals gmbh - thiotepa - hematopoietic stem cell transplantation; neoplasms - antineoplastiske midler - thiotepa riemser is indicated, in combination with other chemotherapy medicinal products:with or without total body irradiation (tbi), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (hpct) in haematological diseases in adult and paediatric patients;when high dose chemotherapy with hpct support is appropriate for the treatment of solid tumours in adult and paediatric patients. thiotepa riemser is indicated, in combination with other chemotherapy medicinal products:with or without total body irradiation (tbi), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (hpct) in haematological diseases in adult and paediatric patients;when high dose chemotherapy with hpct support is appropriate for the treatment of solid tumours in adult and paediatric patients.

Herwenda Den Europæiske Union - dansk - EMA (European Medicines Agency)

herwenda

sandoz gmbh - trastuzumab - breast neoplasms; stomach neoplasms - antineoplastiske midler - treatment of metastatic and early breast cancer and metastatic gastric cancer (mgc).